Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection | Zendy

Hiroyuki Gatanaga | Zendy; Tsunefusa Hayashida | Zendy; Junko Tanuma | Zendy; Shinichi Oka | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection

Author(s) -

Hiroyuki Gatanaga,

Tsunefusa Hayashida,

Junko Tanuma,

Shinichi Oka

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit145

Subject(s) - medicine , lamivudine , hepatitis b virus , virology , hepatitis b , antiretroviral therapy , virus , human immunodeficiency virus (hiv) , immunology , viral load

Hepatitis B virus (HBV) infection is common in individuals infected with human immunodeficiency virus, especially in men who have sex with men (MSM). Almost all currently used regimens of antiretroviral therapy (ART) contain lamivudine (LAM) or tenofovir disoproxil fumarate (TDF), both of which have significant anti-HBV activity. However, the prophylactic effect of ART on HBV infection has not been assessed previously.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research